Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA site-wide NIH notice about terminology changing from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.6%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedNew history entries show that study results have been posted and new results-related sections (Outcome Measures (Results)) and the Limitations and Caveats have been added, along with an updated Study Status. The previous entry 'Results Submitted' has been removed in favor of these current, results-focused updates.SummaryDifference0.5%

- Check56 days agoChange DetectedA new revision v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check70 days agoChange DetectedThe history page now displays Revision: v3.6.6 instead of Revision: v3.6.5, reflecting a small software update.SummaryDifference0.1%

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.